Islam Osman
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- HER2/EGFR in Cancer Research
Papers in
-
- Metabolism, Diabetes, and Cancer 5
- Gut microbiota and health 2
- Epigenetics and DNA Methylation 2
- Oncology 5
- Drug Transport and Resistance Mechanisms 2
- Cancer Diagnosis and Treatment 2
- Co-authors
- Lakshman Segar (5 shared papers)Carlos Cordon‐Cardo (2 shared papers)Howard I. Scher (3 shared papers)H.A. Elsheikh (4 shared papers)Guoqing Hu (7 shared papers)Jiliang Zhou (7 shared papers)Kunzhe Dong (6 shared papers)David B. Agus (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Veterinary Research Communications (2 papers)Modern Pathology (1 paper)Pharmacological Research (1 paper)
- Partner nations
- United StatesChinaSudan
In The Last Decade
Islam Osman
29 papers receiving 778 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 177
- Oncology 141
- Molecular Medicine 26
- Pulmonary and Respiratory Medicine 131
- Molecular Biology 291
Countries citing papers authored by Islam Osman
This map shows the geographic impact of Islam Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam Osman more than expected).
Fields of papers citing papers by Islam Osman
This network shows the impact of papers produced by Islam Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam Osman. The network helps show where Islam Osman may publish in the future.
Co-authors
The 25 scholars most cited alongside Islam Osman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. | 2001 | 130 |
| 2 | 2018 | 109 | |
| 3 | Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. | 1999 | 87 |
| 4 | 2008 | 69 | |
| 5 | 2019 | 60 | |
| 6 | 2015 | 52 | |
| 7 | 2017 | 44 | |
| 8 | 2019 | 40 | |
| 9 | 1997 | 29 | |
| 10 | 2002 | 25 | |
| 11 | 2021 | 24 | |
| 12 | 2014 | 21 | |
| 13 | 1999 | 19 | |
| 14 | 2020 | 16 | |
| 15 | 2018 | 13 | |
| 16 | Long noncoding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) is critical for phenotypic switching of vascular smooth muscle cells | 2018 | 12 |
| 17 | 2021 | 10 | |
| 18 | 1997 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2017 | 4 |
About Islam Osman
Islam Osman is a scholar working on Molecular Biology, Oncology, Pharmacology, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 29 papers that have together received 799 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Gut microbiota and health (2 papers), Diabetes Treatment and Management (2 papers), Cancer Diagnosis and Treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (177 citations), Oncology (141 citations), Molecular Medicine (26 citations), Pulmonary and Respiratory Medicine (131 citations) and Molecular Biology (291 citations). Islam Osman has collaborated with scholars based in United States, China and Sudan. Frequent co-authors include Lakshman Segar, Carlos Cordon‐Cardo, Howard I. Scher, H.A. Elsheikh, Guoqing Hu, Jiliang Zhou, Kunzhe Dong, David B. Agus, Michael J. Morris and David Verbel. Their work appears in journals such as Biochemical Pharmacology, Proceedings of the National Academy of Sciences, Veterinary Research Communications, Modern Pathology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.